Skip to main content
. Author manuscript; available in PMC: 2013 Dec 31.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2010 Jun 18;80(2):10.1016/j.ijrobp.2010.02.005. doi: 10.1016/j.ijrobp.2010.02.005

Table 2.

Patient population classified by status of D353E (rs560191)

Variable CC–CG patients GG patients p Value
No. of patients 124 52 Not applicable
Age (mean) (y) 38 44 < 0.001
Race 30% AA 69% AA < 0.001
87% CA 13% CA
T stage 57% T1 52% T1 0.34
26% T2 34% T2
17% Tis 13% Tis
N stage 78% node negative 71% node negative 0.37
ER status 51% ER positive 30% ER positive 0.03
PR status 46% PR positive 36% PR positive 0.29
HER2/Neu status 34% HER2 positive 31% HER2 positive 0.81
Margins 4% positive 6% positive 0.91
Family history 17% strong 25% strong 0.28
BRCA1/2 status 11% positive 8% positive 0.57
Adjuvant chemotherapy 50% 49% 0.90
Adjuvant hormones 23% 15% 0.25

Abbreviations: ER= estrogen receptor; PR= progesterone receptor.